Pictet Asset Management Holding SA Acquires 33,013 Shares of Core Scientific, Inc. $CORZ

Pictet Asset Management Holding SA boosted its holdings in shares of Core Scientific, Inc. (NASDAQ:CORZ) by 85.7% during the fourth quarter, HoldingsChannel reports. The fund owned 71,525 shares of the company’s stock after purchasing an additional 33,013 shares during the quarter. Pictet Asset Management Holding SA’s holdings in Core Scientific were worth $1,041,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Allworth Financial LP grew its holdings in Core Scientific by 206.5% during the 3rd quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock worth $25,000 after acquiring an additional 950 shares during the last quarter. Osaic Holdings Inc. grew its holdings in Core Scientific by 112.1% during the 2nd quarter. Osaic Holdings Inc. now owns 2,017 shares of the company’s stock worth $34,000 after acquiring an additional 1,066 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in Core Scientific by 61.9% during the 2nd quarter. Russell Investments Group Ltd. now owns 3,942 shares of the company’s stock worth $67,000 after acquiring an additional 1,507 shares during the last quarter. Athos Capital Ltd bought a new stake in Core Scientific during the 3rd quarter worth approximately $76,000. Finally, Wilmington Savings Fund Society FSB bought a new stake in Core Scientific during the 3rd quarter worth approximately $90,000.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on CORZ shares. Wall Street Zen raised shares of Core Scientific to a “sell” rating in a report on Saturday, March 14th. Weiss Ratings reissued a “sell (d-)” rating on shares of Core Scientific in a report on Monday, April 20th. HC Wainwright reissued a “buy” rating and set a $25.00 target price on shares of Core Scientific in a report on Tuesday, March 3rd. Cantor Fitzgerald boosted their target price on shares of Core Scientific from $25.00 to $29.00 and gave the stock an “overweight” rating in a report on Thursday, April 9th. Finally, Keefe, Bruyette & Woods boosted their target price on shares of Core Scientific from $19.00 to $25.00 and gave the stock a “moderate buy” rating in a report on Tuesday, January 27th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, three have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $25.07.

Trending Headlines about Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Acquisition to accelerate Oklahoma buildout — Core Scientific signed a deal to acquire Polaris DS LLC for ~$421M to add land, substation access and up to ~440 MW of gross power adjacent to its Muskogee campus, supporting the company’s plan to scale Muskogee to ~1.5 GW of gross power and speed delivery of high‑density colocation capacity for AI/HPC customers. This is a direct growth catalyst for future revenue from AI customers. Polaris Acquisition
• Positive Sentiment: Capital plan to fund AI colocation expansion — Company announcements and coverage indicate Core Scientific has raised or arranged major financing (~$3.3B reported) aimed at expanding AI/high‑density colocation capacity, which supports aggressive buildout plans and de‑risking of future capacity starts. Financing for Expansion
• Positive Sentiment: Strong market interest / options flow — Unusual activity: a large increase in call option buying (roughly 196k calls), signaling bullish speculative or hedged institutional interest ahead of/after the corporate announcements. (No direct link available in feed.)
• Neutral Sentiment: Corporate governance update — Appointment of Jorge Ray as Principal Accounting Officer (April 30) is a routine exec hire that may modestly affect investor confidence in financial controls but is not an immediate earnings driver. Accounting Officer Appointment
• Negative Sentiment: Q1 earnings miss — Core Scientific reported a wider-than-expected Q1 EPS loss (MarketBeat cites ($1.06) EPS vs. consensus ≈ ($0.02)) and revenue slightly below estimates ($115.2M vs $117.0M). The EPS miss is the main negative catalyst and explains near‑term selling pressure in some sessions. Q1 Release
• Negative Sentiment: Insider selling — Director/officer Todd M. Duchene sold 10,000 shares at an average of $20.86 (disclosed), a small but visible insider sale that can be interpreted negatively by some investors. SEC Form 4

Insider Activity

In related news, insider Todd M. Duchene sold 10,000 shares of Core Scientific stock in a transaction on Monday, May 4th. The shares were sold at an average price of $20.86, for a total value of $208,600.00. Following the completion of the sale, the insider owned 1,980,348 shares of the company’s stock, valued at approximately $41,310,059.28. This trade represents a 0.50% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In the last quarter, insiders sold 50,000 shares of company stock valued at $933,400. 1.70% of the stock is owned by company insiders.

Core Scientific Stock Performance

CORZ stock opened at $24.63 on Thursday. The stock’s 50 day simple moving average is $17.66 and its 200 day simple moving average is $17.47. The company has a market cap of $7.77 billion, a P/E ratio of 21.05 and a beta of 5.45. Core Scientific, Inc. has a fifty-two week low of $8.74 and a fifty-two week high of $25.01.

Core Scientific (NASDAQ:CORZ) last announced its quarterly earnings data on Wednesday, May 6th. The company reported ($1.06) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($1.04). The business had revenue of $115.24 million during the quarter, compared to analysts’ expectations of $117.04 million. During the same period in the previous year, the business earned $1.25 earnings per share. The business’s revenue for the quarter was up 44.9% on a year-over-year basis. Equities analysts predict that Core Scientific, Inc. will post 0.07 earnings per share for the current year.

About Core Scientific

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.